One can cite quercitin [223], berberin derivatives (EPO Patent 0813872-A1), paclitaxel [224], KNK437 [225] and interferon-γ which suppresses HspB1 basal transcription and promoter activity thus enhancing hyperthermia-induced tumor cell death in vitro and tumor suppression in vivo [226,227]. Here, EPO is linked to neoplasm.